|
ENGAGE: Evaluation of a streamlined oncologist-led BRCA mutation (BRCAm) testing and counselling model for patients with ovarian cancer. |
|
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
|
Speakers' Bureau - AstraZeneca |
Research Funding - AstraZeneca |
|
|
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Baxalta (Inst) |
|
|
Honoraria - AstraZeneca; pharmamar; Roche |
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro |
Research Funding - MSD (Inst); Pfizer (Inst); Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Biologics, Inc |
Research Funding - AstraZeneca |
|
|
Research Funding - Advaxis |
|
Santiago Gonzalez Santiago |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Amgen; AstraZeneca; Gilead Sciences; Sanofi |
|
|
No Relationships to Disclose |
|
|
Employment - AstraZeneca; Mapi Values |
|
|
Employment - AstraZeneca; Mapi |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
Employment - AstraZeneca; Worldwide Clinical Trials |
Stock and Other Ownership Interests - Pfizer |